PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome

EJNMMI Research

Table 1 Baseline patients’ characteristics

Characteristics	PSMA expression			Overall
	Negative	Positive		Overall
	Score 0 (n = 12)	Score 1 (n = 25)	Score 2 (n = 22)	N = 59
Age
< 55 years	8	12	13	33
≥ 55 years	4	13	9	26
Sex
Male	3	6	5	14
Female	9	19	17	45
Histological DTC subtype
Well differentiated
Papillary	12	21	16	49
Follicular	0	2	2	4
Poorly differentiated	0	2	4	6
Primary tumor site
Left lobe	7	8	11	26
Right lobe	2	13	7	22
Left lobe + right lobe	2	2	4	8
Isthmus	0	1	0	1
Left lobe + isthmus	0	1	0	1
Right lobe + isthmus	1	0	0	1
TNM
T1/T2	6	17	10	33
T3/T4	6	8	12	26
N0	7	19	12	38
N+	5	6	10	21
M0	12	22	16	50
M+	0	3	6	9
Stage
I/II	12	20	15	47
III/IV	0	5	7	12
Vascular invasion
No	6	16	7	29
Yes	6	9	15	30
Status of surgical margins
Free	9	20	16	45
Involved	3	5	6	14
Recurrence
No	9	19	12	40
Yes	3	6	10	19
Radioiodine refractoriness
No	10	21	16	47
Yes	2	4	6	12
Status at last follow-up
No evidence of disease	10	21	15	46
Recurrence/progressive disease or death	2	4	7	13